162 related articles for article (PubMed ID: 2511625)
1. Predictive markers of AIDS: a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphadenopathy.
Böttiger B; Morfeldt-Månson L; Putkonen P; Nilsson B; Julander I; Biberfeld G
Scand J Infect Dis; 1989; 21(5):507-14. PubMed ID: 2511625
[TBL] [Abstract][Full Text] [Related]
2. CD4 lymphocyte counts and serum p24 antigen of no diagnostic value in monitoring HIV-infected patients with pulmonary symptoms.
Orholm M; Nielsen TL; Nielsen JO; Lundgren JD
AIDS; 1990 Feb; 4(2):163-6. PubMed ID: 1970256
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.
Mulder JW; Krijnen P; Goudsmit J; Schattenkerk JK; Reiss P; Lange JM
Genitourin Med; 1990 Jun; 66(3):138-41. PubMed ID: 2115018
[TBL] [Abstract][Full Text] [Related]
4. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 neutralizing antibodies in urine from seropositive individuals.
Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
[TBL] [Abstract][Full Text] [Related]
6. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
7. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
[TBL] [Abstract][Full Text] [Related]
8. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.
Moss AR; Bacchetti P; Osmond D; Krampf W; Chaisson RE; Stites D; Wilber J; Allain JP; Carlson J
Br Med J (Clin Res Ed); 1988 Mar; 296(6624):745-50. PubMed ID: 3126959
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory characteristics of HIV-1 infection in Zimbabwe.
Katzenstein DA; Latif AS; Grace SA; Basset M; Mashu A; de Villiers DM; Carrow EW; Hendry RM; Marowa E; Emmanuel JC
J Acquir Immune Defic Syndr (1988); 1990; 3(7):701-7. PubMed ID: 1972189
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection.
Croxson TS; Mathur-Wagh U; Handwerger S; Siroty WE; Kaminisky D; Reagan KJ; Yancovitz SR; Mildvan D
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):455-63. PubMed ID: 2111160
[TBL] [Abstract][Full Text] [Related]
11. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus (HIV) infection in haemophiliacs: long-term prognostic significance of the HIV serologic pattern.
Raska K; Kim HC; Raska K; Martin E; Raskova J; Saidi P
Clin Exp Immunol; 1989 Jul; 77(1):1-6. PubMed ID: 2504517
[TBL] [Abstract][Full Text] [Related]
13. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
Chargelegue D; Colvin BT; O'Toole CM
AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
[TBL] [Abstract][Full Text] [Related]
14. Appearance of predictors of disease progression in relation to the development of AIDS.
de Wolf F; Lange JM; Houweling JT; Mulder JW; Beemster J; Schellekens PT; Coutinho RA; van der Noordaa J; Goudsmit J
AIDS; 1989 Sep; 3(9):563-9. PubMed ID: 2571348
[TBL] [Abstract][Full Text] [Related]
15. Immune pathogenesis of AIDS and related syndromes.
Fahey JL; Giorgi J; Martínez-Maza O; Detels R; Mitsuyasu R; Taylor J
Ann Inst Pasteur Immunol; 1987; 138(2):245-52. PubMed ID: 2955795
[TBL] [Abstract][Full Text] [Related]
16. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
[TBL] [Abstract][Full Text] [Related]
17. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
[TBL] [Abstract][Full Text] [Related]
18. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
19. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
20. Actuarial rate of clinical and biological progression in a cohort of 250 HIV-1-seropositive subjects. Laennec HIV Study Group.
Venet A; Tourani JM; Beldjord K; Eme D; Even P; Andrieu JM
Clin Exp Immunol; 1990 May; 80(2):151-5. PubMed ID: 1972669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
